[Pharmacological actions interfering with the development of experimental inflammatory reactions].
D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000962:Antimalarials / Q000494:pharmacology; D002351:Carrageenan / Q000633:toxicity; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003543:Cysteamine / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D004487:Edema / Q000139:chemically induced; D006099:Granuloma / Q000139:chemically induced; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced*; D009132:Muscles / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013390:Succinylcholine / Q000494:pharmacology
D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D003543:Cysteamine; D002351:Carrageenan; D012964:Sodium; D013390:Succinylcholine; D003545:Cysteine
Azioni farmacologiche interferenti nello sviluppo di reazioni inflammatory sperimentali.